Month: June 2022

CALGARY, Alberta and TORONTO, June 09, 2022 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC; MNC.PR.A) (“Magnetic North” or the “Company”) announces that it has decided to restate its financial statements for the year ended December 31, 2020 (the “2020 Restatement”). The decision to restate followed a review conducted by the Company’s new auditor and management’s consideration of the application of IFRS 10 for the Company’s investment companies, wherein it was determined that the consolidation of investment in CXTL Recycling (Canada) Corp. included in the financial statements as well as the application of other accounting policies were not appropriate given that Magnetic North is an investment entity. The material changes to be included in the 2020 Restatement will affect the Company’s balance sheet and income statement....

MALVERN, Pa., June 09, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, today announced that Michael Shine, Ocugen’s Senior Vice President, Commercial, will present at the 2022 BIO International Convention being held in San Diego, California, from June 13-16, 2022. The Company presentation, which is scheduled for Monday, June 13, at 4:45 p.m. PT in Meeting Room 1 of the San Diego Convention Center, will focus on Ocugen’s robust clinical pipeline, including its COVID-19 vaccine candidate, COVAXIN™ (BBV152), its modifier gene therapy programs, and its new cell therapy program, NeoCart®. About Ocugen, Inc.Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing...

CALGARY, Alberta, June 09, 2022 (GLOBE NEWSWIRE) — Canadian Spirit Resources Inc. (“CSRI” or the “Corporation”) (TSXV:SPI) (OTCBB:CSPUF) is pleased to announce the appointment of Greg Florence as Chief Financial Officer (“CFO”) of the Corporation, effective immediately, replacing Sead Hamzagic who is stepping down as CFO to pursue other opportunities. Greg Florence is a Chartered Professional Accountant and has over 30 years of business and financial experience in various sectors including upstream oil and gas. Mr. Florence has held several senior management positions with public and private companies, including CFO, Corporate Secretary, Director Investments, and Vice President marketing and Corporate Development. The board welcomes Mr. Florence and wishes to thank Mr. Hamzagic for his contribution since joining the...

LINDON, Utah, June 09, 2022 (GLOBE NEWSWIRE) — Profire Energy, Inc. (NASDAQ: PFIE), a technology company (the “Company”) that provides solutions which enhance the efficiency, safety, and reliability of industrial combustion appliances, today announced that Ryan Oviatt, Co-Chief Executive Officer and Chief Financial Officer, & Cameron Tidball, Co-Chief Executive Officer, will participate in the virtual East Coast IDEAS Investor Conference on June 23, 2022. The Company’s presentation and webcast is scheduled to be available at 6:00 am ET on June 22nd and will be accessible through the conference website: www.IDEASconferences.com. Anyone interested in participating or learning more about the IDEAS conferences should contact Steven Hooser at (214) 872-2710 or shooser@threepa.com. About Profire Energy, Inc. Profire...

Not for distribution to United States news wire services or dissemination in the United States. ST. JOHN’S, Newfoundland and Labrador, June 09, 2022 (GLOBE NEWSWIRE) — Fortis Inc. (TSX: FTS) (“Fortis” or the “Corporation”) announced today the redemption price for its outstanding 2.85% Senior Unsecured Notes due December 12, 2023 (the “Notes”). The redemption of all $500,000,000 aggregate principal amount of the Notes was announced by the Corporation on May 9, 2022 and is effective as of today (the “Redemption Date”). The redemption price is $1,013.977 per $1,000 principal amount of the Notes, which includes interest accrued to but excluding the Redemption Date in the amount of $13.977. The redemption price has been calculated in accordance with the terms of the base indenture...

Company Announcement COPENHAGEN, Denmark; June 9, 2022 – Genmab A/S (Nasdaq: GMAB) announced today that it has commenced a new arbitration under its license agreement with Janssen Biotech, Inc. (Janssen) for daratumumab. This new arbitration follows from the award in the prior arbitration, where the tribunal ruled in favor of Janssen on the question as to whether Genmab is required to share in Janssen’s royalty payments to Halozyme Therapeutics, Inc. for its technology used in the subcutaneous formulation of daratumumab (marketed as DARZALEX FASPRO® in the United States), cf. Company Announcement No 14. The tribunal based its ruling on the finding that DARZALEX FASPRO constitutes a new licensed product under the license agreement. In this new arbitration, Genmab is consequently seeking an award of $405 million plus interest in accrued...